| Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter‐related bloodstream infection S Zanwar, P Jain, A Gokarn, SK Devadas, S Punatar, S Khurana, A Bonda, ... Transplant Infectious Disease 21 (1), e13017, 2019 | 41 | 2019 |
| COVID‐19 in cancer patients on active systemic therapy–outcomes from LMIC scenario with an emphasis on need for active treatment A Ramaswamy, L Nayak, N Roy Moulik, M Sengar, G Chinnaswamy, ... Cancer Medicine 9 (23), 8747-8753, 2020 | 37 | 2020 |
| Daratumumab at the frontiers of post-transplant refractory T-acute lymphoblastic leukemia—a worthwhile strategy? A Bonda, S Punatar, A Gokarn, A Mohite, K Shanmugam, L Nayak, ... Bone Marrow Transplantation 53 (11), 1487-1489, 2018 | 34 | 2018 |
| Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol A Rajendra, H Jain, VNA Bonda, L Nayak, P Tembhare, D Shetty, J Thorat, ... Blood advances 5 (5), 1178-1193, 2021 | 26 | 2021 |
| Use of leflunomide for treatment of cytomegalovirus infection in recipients of allogeneic stem cell transplant A Gokarn, A Toshniwal, A Pathak, S Arora, A Bonda, S Punatar, L Nayak, ... Biology of Blood and Marrow Transplantation 25 (9), 1832-1836, 2019 | 25 | 2019 |
| Bilateral adenomyoepithelioma of breast J Bajpai, SB Punatar, A Gupta, R Badwe, S Gupta Journal of Cancer research and Therapeutics 9 (3), 523-525, 2013 | 24 | 2013 |
| A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001) A Agarwal, A Khandelwal, K Pal, NK Khare, V Jadhav, M Gurjar, ... PLoS One 17 (2), e0262212, 2022 | 17 | 2022 |
| Risk factors, pattern and clinical outcome of acute graft versus host disease in acute leukemia patients undergoing allogeneic stem cell transplant A Gupta, S Punatar, J Gawande, L Mathew, B Bagal, S Kannan, N Khattry Indian Journal of Hematology and Blood Transfusion 31, 404-412, 2015 | 13 | 2015 |
| Sunitinib-induced thrombotic microangiopathy V Noronha, S Punatar, A Joshi, RV Desphande, K Prabhash Journal of cancer research and therapeutics 12 (1), 6-11, 2016 | 12 | 2016 |
| Thyroid cancer in Gardner’s syndrome: Case report and review of literature SB Punatar, V Noronha, A Joshi, K Prabhash South Asian Journal of Cancer 1 (01), 43-47, 2012 | 12 | 2012 |
| Lomustine, cytarabine, cyclophosphamide, etoposide–An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed … A Gupta, A Gokarn, D Rajamanickam, S Punatar, R Thippeswamy, ... Journal of Cancer Research and Therapeutics 14 (5), 926-933, 2018 | 11 | 2018 |
| Phase III randomized trial comparing intravenous to oral iron in patients with cancer‐related iron deficiency anemia not on erythropoiesis stimulating agents V Noronha, A Joshi, VM Patil, SD Banavali, S Gupta, PM Parikh, ... Asia‐Pacific Journal of Clinical Oncology 14 (2), e129-e137, 2018 | 11 | 2018 |
| Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: an institutional audit N Khattry, S Laskar, M Sengar, V Rangarajan, T Shet, PG Subramanian, ... Indian Journal of Cancer 55 (1), 9-15, 2018 | 11 | 2018 |
| Hepatitis B‐related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation A Gupta, S Punatar, J Gawande, B Bagal, L Mathew, V Bhat, S Kannan, ... Hematological oncology 34 (3), 140-146, 2016 | 11 | 2016 |
| Chronic graft versus host disease in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplant: analysis of risk factors, pattern and long term outcome S Punatar, A Gupta, J Gawande, B Bagal, L Mathew, S Kannan, N Khattry Indian Journal of Hematology and Blood Transfusion 32, 32-38, 2016 | 11 | 2016 |
| Real-world outcomes with generic pomalidomide in relapsed refractory multiple myeloma—experience from a Tertiary Care Cancer Center SK Bondili, B Bagal, A Zawar, P Ventrapati, J Thorat, A Gokarn, S Punatar, ... JCO Global Oncology 7, 361-367, 2021 | 10 | 2021 |
| Analysis of factors affecting initial cyclosporine level and its impact on post transplant outcomes in acute leukemia A Gupta, S Punatar, J Gawande, L Mathew, S Kannan, N Khattry Journal of Cancer Research and Therapeutics 13 (6), 981-988, 2017 | 9 | 2017 |
| Cyclosporine plus methotrexate or cyclosporine plus mycophenolate mofetil as graft versus host disease prophylaxis in acute leukemia transplant: comparison of toxicity … A Gupta, S Punatar, L Mathew, S Kannan, N Khattry Indian Journal of Hematology and Blood Transfusion 32, 248-256, 2016 | 9 | 2016 |
| Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia B Shriyan, P Mehta, A Patil, S Jadhav, S Kumar, AS Puri, R Govalkar, ... European Journal of Clinical Pharmacology 78 (8), 1321-1330, 2022 | 7 | 2022 |
| N Gene Target Failure (NGTF) for detection of Omicron: a way out for the ‘stealth’too? S Harankhedkar, G Chatterjee, S Rajpal, A Khan, T Srivastava, S Mirgh, ... MedRxiv, 2022.01. 28.22269801, 2022 | 7 | 2022 |